Cold-Pressed Flaxseed Oil (Linum usitatissimum)

Cold-pressed flaxseed oil is derived from Linum usitatissimum seeds and contains approximately 55.68% alpha-linolenic acid (ALA), an essential omega-3 fatty acid the body cannot synthesize. ALA is converted to EPA and DHA via elongase and desaturase enzymes, supporting inflammatory regulation and cardiovascular function.

Origin & History

Cold-pressed flaxseed oil is mechanically extracted from Linum usitatissimum (flax) seeds at room temperature without chemical solvents or heat, preserving its nutritional profile. This extraction method maintains higher concentrations of omega-3 fatty acids (55.68% ALA), tocopherols, and sterols compared to conventional solvent extraction.

Historical & Cultural Context

The research dossier does not contain information about traditional or historical use of flaxseed oil in any medicine systems. No cultural context or traditional applications are documented in the provided sources.

Health Benefits

• The research dossier does not contain clinical evidence for specific health benefits
• Chemical analysis shows 55.68% alpha-linolenic acid (ALA) content, an essential omega-3 fatty acid
• Contains 115.35 mg/100g total tocopherols with antioxidant properties
• Higher sterol content (339.29 mg/100g) compared to solvent-extracted oils
• Better oxidative stability and unsaturation levels preserved through cold-pressing

How It Works

Alpha-linolenic acid (ALA) in flaxseed oil is converted by delta-6-desaturase and elongase enzymes to EPA and DHA, which serve as precursors to anti-inflammatory eicosanoids and resolvins that compete with arachidonic acid at COX and LOX enzyme pathways. Plant sterols at 339.29 mg/100g inhibit intestinal cholesterol absorption by displacing cholesterol from bile acid micelles, reducing circulating LDL. Tocopherols at 115.35 mg/100g neutralize lipid peroxyl radicals via hydrogen donation, protecting polyunsaturated fatty acids from oxidative degradation.

Scientific Research

The provided research dossier contains no human clinical trials, randomized controlled trials, or meta-analyses with PMIDs. The available data focuses exclusively on chemical composition and extraction methodology comparisons between cold-pressed and solvent-extracted flaxseed oils.

Clinical Summary

Clinical evidence specific to cold-pressed flaxseed oil as an isolated supplement is currently limited in the available research dossier, making direct efficacy conclusions premature. Broader research on ALA-rich oils suggests modest cardiovascular benefits, including reductions in systolic blood pressure of approximately 2-3 mmHg in meta-analyses of randomized controlled trials. Plant sterol research across multiple RCTs demonstrates LDL reductions of 5-15% at intakes of 1.5-3 g/day, though typical flaxseed oil serving sizes may not reach therapeutic sterol thresholds. Overall evidence quality for cold-pressed flaxseed oil specifically should be considered preliminary until dedicated clinical trials are conducted.

Nutritional Profile

Cold-pressed flaxseed oil is composed predominantly of polyunsaturated fatty acids, with alpha-linolenic acid (ALA, omega-3) as the dominant fatty acid at 55.68% of total lipid content, making it one of the richest plant-based sources of ALA. Linoleic acid (omega-6) is present at approximately 14-17% of total fatty acids, with oleic acid (omega-9, monounsaturated) contributing approximately 18-20%. Saturated fatty acids, primarily palmitic and stearic acids, account for approximately 9-11% of total fatty acids. Total tocopherol content is 115.35 mg/100g, providing antioxidant activity; gamma-tocopherol is the predominant tocopherol fraction in flaxseed oil. Phytosterol content is notably high at 339.29 mg/100g (higher than solvent-extracted equivalents), with beta-sitosterol, campesterol, and stigmasterol as the primary sterols. The cold-pressing process preserves oxidative stability and unsaturation integrity better than solvent extraction methods. Flaxseed oil contains no fiber, negligible protein, and minimal carbohydrates as a refined lipid fraction. ALA bioavailability is moderate; conversion to EPA and DHA in humans is limited (estimated 5-15% to EPA, less than 1% to DHA), meaning it does not fully substitute for marine omega-3 sources. No significant vitamin or mineral content beyond tocopherols is documented in the available data.

Preparation & Dosage

No clinically studied dosage ranges are available in the provided research. The dossier lacks information on standardized preparations, extract forms, or powder formulations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to determine synergistic ingredients

Safety & Interactions

Cold-pressed flaxseed oil is generally well tolerated at typical doses of 1-2 tablespoons daily, with the most common side effects being loose stools, bloating, and nausea due to its high fat content. Because ALA has mild antiplatelet effects, concurrent use with anticoagulants such as warfarin or direct oral anticoagulants (DOACs) may increase bleeding risk and warrants medical supervision. Flaxseed oil may lower blood pressure additively when combined with antihypertensive medications, and may modestly reduce blood glucose, requiring monitoring in diabetic patients on hypoglycemic agents. Safety data in pregnancy is insufficient to make strong recommendations; whole flaxseed contains lignans with weak estrogenic activity, though oil contains far fewer lignans, and caution is still advised during pregnancy and breastfeeding.